ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 2 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $396,939 | -28.8% | 86,291 | 0.0% | 0.21% | -26.7% |
| Q2 2023 | $557,440 | -14.3% | 86,291 | 0.0% | 0.28% | -14.1% |
| Q1 2023 | $650,634 | -25.6% | 86,291 | 0.0% | 0.33% | -31.3% |
| Q4 2022 | $874,128 | +2.5% | 86,291 | 0.0% | 0.48% | +13.3% |
| Q3 2022 | $853,000 | -27.2% | 86,291 | -21.6% | 0.42% | -8.7% |
| Q2 2022 | $1,172,000 | +31.8% | 110,047 | +20.7% | 0.46% | +89.3% |
| Q1 2022 | $889,000 | -32.7% | 91,200 | -1.3% | 0.24% | +3.4% |
| Q4 2021 | $1,321,000 | -53.9% | 92,358 | -35.4% | 0.24% | -20.6% |
| Q3 2021 | $2,865,000 | – | 142,970 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $17,358,238 | 89.37% |
| Founders Fund Growth Management, LLC | 407,017 | $1,872,278 | 5.10% |
| Prosight Management, LP | 2,446,000 | $11,251,600 | 3.57% |
| Intellectus Partners, LLC | 876,633 | $4,032,511 | 1.28% |
| Belmont Capital, LLC | 510,000 | $2,346,000 | 1.27% |
| Casdin Capital, LLC | 2,360,129 | $10,856,593 | 1.20% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $7,842,357 | 0.88% |
| Baker Brothers Advisors | 20,763,323 | $95,511,286 | 0.55% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $262,090 | 0.44% |
| Orbimed Advisors | 4,180,768 | $19,231,533 | 0.41% |